InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Explore the complete record of transactions filed by Tian Wenzhi, 管理人员. Director active across 2 companies, notably ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B. Cumulatively, 2 filings have been recorded. History available since 13 May 2026. The latest transaction was disclosed on 13 May 2026 (Purchase). Regulator: HKEX. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Tian Wenzhi is an executive at ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares. He is responsible for managing operations and developing new treatments in the biopharmaceutical field. Tian contributes to innovation and advancement of therapeutic solutions aimed at improving patient health.